Gland Pharma Limited

Q3 Results Impact: SBI Card, SBI Life Slip 3%, Gland Pharma Jumps 9% on Earnings Reaction

The Q3 results impact was clearly visible on Dalal Street as earnings numbers drove sharp, stock-specific moves on January 29. While SBI Card and SBI Life Insurance saw selling pressure after their December-quarter numbers failed to meet market sentiment, Gland Pharma stood out with a strong rall...

Pharma Stocks Plunge: Sun Pharma, Aurobindo, Cipla, Lupin Fall as Trump Cracks Down on Global Drug Prices

Market PerformancePharma stocks witnessed a sharp sell-off on Friday, triggered by new developments from the United States that rattled investor sentiment.The Nifty Pharma index fell over 2.8%, marking its third consecutive day of decline.Sun Pharma led the fall with a 4% drop, becoming the worst...

Pharma Stocks Slide: Aurobindo Pharma, Lupin, Dr Reddy’s, and Others See Sharp Decline Amid Tariff Concerns

Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...

Nifty Pharma Index Declines Amid U.S. Tariff Announcement

Market PerformanceOn April 9, the Nifty Pharma index registered a sharp decline during early trading hours, dropping by 2 percent to 19,964.10. This continued a broader downward trend observed over the past six months, during which the index has fallen approximately 14 percent. All constituent st...